Anne‐Laure Pointet

机构：Université Paris Cité, Assistance Publique – Hôpitaux de Paris, Hôpital Européen Georges-Pompidou

发表论文 24 篇 · 总被引 1439 次 · h-index 9

代表论文

• VEGF-A modulates expression of inhibitory checkpoints on CD8+ T cells in tumors (2015 · The Journal of Experimental Medicine · 被引 1181)
• Folfirinox versus gemcitabine/nab-paclitaxel as first-line therapy in patients with metastatic pancreatic cancer: a comparative propensity score study (2019 · Therapeutic Advances in Gastroenterology · 被引 70)
• Prediction of survival with second-line therapy in biliary tract cancer: Actualisation of the AGEO CT2BIL cohort and European multicentre validations (2019 · European Journal of Cancer · 被引 45)
• Additive value of pre-operative and one-month post-operative lymphocyte count for death-risk stratification in patients with resectable pancreatic cancer: a multicentric study (2016 · BMC Cancer · 被引 33)
• Prognostic value of health-related quality of life in patients with metastatic pancreatic adenocarcinoma: a random forest methodology (2015 · Quality of Life Research · 被引 33)
• Fluropyrimidine single agent or doublet chemotherapy as second line treatment in advanced biliary tract cancer (2020 · International Journal of Cancer · 被引 26)